Safety and Immunogenicity of Vi-DT Typhoid Conjugate Vaccine in Indonesian Adults, Adolescents, Children and Infants

PHASE2CompletedINTERVENTIONAL

Enrollment

600

Participants

Timeline

Start Date

July 16, 2018

Primary Completion Date

December 31, 2019

Study Completion Date

January 30, 2020

Conditions

Safety IssuesImmunogenicity

Interventions

BIOLOGICAL

Vi-DT Vaccine

1 dose of Vi-DT Vaccine

BIOLOGICAL

Vi Polysaccharide Vaccine

1 dose of Vi Polysaccharide Vaccine

BIOLOGICAL

IPV Vaccine

1 dose of IPV Vaccine

Trial Locations (2)

Puskesmas Jatinegara, Jakarta

Puskesmas Senen, Jakarta